pcDNA3.1-DTYMK Citations (1)
Originally described in: Pyrimidine metabolic rate limiting enzymes in poorly-differentiated hepatocellular carcinoma are signature genes of cancer stemness and associated with poor prognosis.Yeh HW, Lee SS, Chang CY, Hu CM, Jou YS Oncotarget. 2017 Sep 8;8(44):77734-77751. doi: 10.18632/oncotarget.20774. eCollection 2017 Sep 29. PubMed Journal
Articles Citing pcDNA3.1-DTYMK
| Articles |
|---|
Pyrimidine metabolic rate limiting enzymes in poorly-differentiated hepatocellular carcinoma are signature genes of cancer stemness and associated with poor prognosis.
Yeh HW, Lee SS, Chang CY, Hu CM, Jou YS.
Oncotarget. 2017 Sep 8;8(44):77734-77751. doi: 10.18632/oncotarget.20774. eCollection 2017 Sep 29.
PubMed
Associated Plasmids |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.